| Bioactivity | HYNIC-iPSMA TFA is a ligand for molecular imaging of tumors. Hynic-ipsma consists of two components: HYNIC (6-hydrazinonicotinamide) and iPSMA (Inhibitor of Prostate-Specific Membrane Antigen). HYNIC is a compound used to attach radioactive isotopes to targeted molecules. iPSMA is a specific inhibitor used to inhibit prostate-specific membrane antigen (PSMA). 68GA-labeled iPSMA has been used to detect prostate cancer by PET imaging. The further 99mTc-EDDA/HYNIC-iPSMA TFA has excellent specificity and sensitivity[1]. | ||||||
| CAS | 2375849-11-7 | ||||||
| Sequence | Hydrazinonicotinyl-Lys(Nal)-Urea-Glu | ||||||
| Shortening | Hydrazinonicotinyl-Lys(Nal)-Urea-Glu | ||||||
| Formula | C33H38F3N7O11 | ||||||
| Molar Mass | 765.69 | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Ferro-Flores G, et al. Clinical translation of a PSMA inhibitor for 99mTc-based SPECT. Nucl Med Biol. 2017 May;48:36-44. |
HYNIC-iPSMA TFA
CAS: 2375849-11-7 F: C33H38F3N7O11 W: 765.69
HYNIC-iPSMA TFA is a ligand for molecular imaging of tumors. Hynic-ipsma consists of two components: HYNIC (6-hydrazinon
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.